Client Challenge

A Chinese pharmaceutical company, faced with the challenges of the COVID-19 pandemic, sought to enhance efficiency and lower expenses related to compliance for its sales representatives who had transitioned from in-person to online events.

Solution

The company, in partnership with Cloudseed, employed the use of robotic process automation (RPA) to bring in seven robots that gather and ready screenshots of online events to guarantee adherence to regulations.

Benefits

The use of robots for gathering screenshots reduces costs associated with third-party agencies and increases efficiency as they can provide 24/7 support. Additionally, it ensures compliance with government regulations.

‍

Meeting safety and compliance requirements

Due to the COVID-19 pandemic, a Chinese pharmaceutical company had to adjust its operations as new restrictions were put in place. Previously, sales representatives would hold seminars and conferences to promote and sell products, but these in-person events were no longer possible. Despite the need for safety precautions, the company still had to find a way for its sales team to connect with hospital staff and medical experts. By moving the seminars online, the company was able to maintain its business operations.

The business had to ensure compliance with regulations by monitoring their online events and providing evidence that they were not being misused by sales representatives. This necessitated assigning a large team to gather and submit screenshots to demonstrate compliance. Recognizing the inefficiency of this manual process, the company sought to automate it in order to lower costs and decrease dependence on outside agencies. To achieve this goal, they partnered with Cloudseed to develop a solution through a dedicated collaboration.

After collaborating, the partners determined that RPA was the optimal solution for meeting the company's objectives of enhancing efficiency and reducing the costs of compliance-related processes. Utilizing tested RPA methodology, business analysts evaluated the organization's current tools and procedures to formulate the necessary steps for completing the project. Once the plan was given the green light by key stakeholders from the pharmaceutical company, the partners initiated the development of multiple robots using UiPath.

Given the ongoing pandemic, the company collaborated entirely remotely throughout the project, which entailed regular coordination and communication with users to guarantee that the automated process met their requirements. This remote access also decreased the overall production cost for the business while allowing the partners to connect more seamlessly while safeguarding employee safety and ensuring that the project progressed in a streamlined and adaptable manner. Finally, once the robots were constructed, the company and Cloudseed conducted thorough testing to identify any issues before introducing the live solution.

‍

RPA drives efficiency and lowers costs

After the project's completion, the company, in partnership with Cloudseed, developed and implemented 7 specialized robots to automatically generate and prepare screenshots for compliance submission. This has enabled the company's sales reps to conduct online events without compliance concerns, allowing the business to redirect its resources elsewhere. The use of RPA technology has also decreased the costs of meeting regulatory compliance by reducing the need for manual labor from external workers. Furthermore, the solution was designed to be user-friendly, allowing any sales representative to easily request a screenshot during a meeting.

As a result of the successful implementation of RPA, the pharmaceutical company and Cloudseed will continue to collaborate and explore new opportunities for automation. Both organizations will continue to innovate and strive for efficiency that aligns with the company's future objectives and supports the efforts of its employees.